SMTL ID : 5v4y.1

X-ray crystal structure of wild type HIV-1 protease in complex with GRL-09510

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

homo-dimer

Ligands

2 x 8FM: (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]carbamate(Non-covalent)

8FM.1: 26 residues within 4Å: Chain A: D.25, G.27, A.28, D.29, D.30, V.32, G.48, G.49, I.50, P.81, V.82, I.84 Chain B: L.23, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.48, G.49, I.50, V.82, I.84 Ligands: 8FM.2 23 PLIP interactions: 14 interactions with chain B, 9 interactions with chain A Hydrophobic interactions: B:L.23, B:I.47, B:I.47, B:V.82, B:I.84, A:A.28, A:V.32, A:P.81, A:V.82, A:I.84 Hydrogen bonds: B:G.27, B:G.27, B:D.29, B:D.30, A:D.30, A:D.30, A:I.50 Water bridges: B:I.50, B:I.50, B:I.50, B:I.50 Salt bridges: B:D.25, A:D.25 8FM.2: 26 residues within 4Å: Chain A: L.23, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.48, G.49, I.50, V.82, I.84 Chain B: D.25, G.27, A.28, D.29, D.30, V.32, G.48, G.49, I.50, P.81, V.82, I.84 Ligands: 8FM.1 22 PLIP interactions: 14 interactions with chain A, 8 interactions with chain B Hydrophobic interactions: A:L.23, A:I.47, A:I.47, A:V.82, A:I.84, B:A.28, B:V.32, B:P.81, B:V.82, B:I.84 Hydrogen bonds: A:G.27, A:G.27, A:D.29, A:D.30, B:D.30, B:I.50 Water bridges: A:I.50, A:I.50, A:I.50, A:I.50 Salt bridges: A:D.25, B:D.25

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Amano, M. et al., GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro. Sci Rep (2017)

Release Date

2017-09-13

Peptides

Protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Protease

Related Entries With Identical Sequence